Lori Lawley
2020
In 2020, Lori Lawley earned a total compensation of $738.7K as Chief Financial Officer at NewLink Genetics.
Compensation breakdown
| Non-Equity Incentive Plan | $214,660 |
|---|---|
| Option Awards | $140,567 |
| Salary | $300,000 |
| Stock Awards | $35,415 |
| Other | $48,050 |
| Total | $738,692 |
Lawley received $300K in salary, accounting for 41% of the total pay in 2020.
Lawley also received $214.7K in non-equity incentive plan, $140.6K in option awards, $35.4K in stock awards and $48.1K in other compensation.
Rankings
In 2020, Lori Lawley's compensation ranked 9,791st out of 13,090 executives tracked by ExecPay. In other words, Lawley earned more than 25.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,791 out of 13,090 | 25th |
Division Manufacturing | 4,207 out of 5,624 | 25th |
Major group Chemicals And Allied Products | 1,725 out of 2,257 | 24th |
Industry group Drugs | 1,512 out of 1,957 | 23rd |
Industry Pharmaceutical Preparations | 1,115 out of 1,462 | 24th |
Source: SEC filing on March 23, 2022.
Lawley's colleagues
We found five more compensation records of executives who worked with Lori Lawley at NewLink Genetics in 2020.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021